Article

Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal…

medRxiv · 2024 · Christina J.F. Courreges, author Elizabeth C.M. Davenport, author Benoit Bilanges, author Elena Rebollo-Gomez, author Jens Hukelmann, author Priya Schoenfelder, author James R. Edgar, author David Sansom, author Cheryl L Scudamore, author Rahul Roychudhuri, author Oliver A. Garden, author Bart Vanhaesebroeck, author Klaus Okkenhaug, author

Key facts

Title Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development
First author Christina J.F. Courreges, author Elizabeth C.M. Davenport, author Benoit Bilanges, author Elena Rebollo-Gomez, author Jens Hukelmann, author Priya Schoenfelder, author James R. Edgar, author David Sansom, author Cheryl L Scudamore, author Rahul Roychudhuri, author Oliver A. Garden, author Bart Vanhaesebroeck, author Klaus Okkenhaug, author
Journal medRxiv
Published Jan 11, 2024
DOI 10.1101/2024.01.08.574346
Devices mentioned BK110039, DEN000008, K022086, K103302, K810863, K912666, K954191, K973350, K982485, K990827
Product codes mentioned DBM, JCI, KIP, KIT, LFZ, MVU, NDS, NJT, NSU, OOI, JLX, KQP and 2 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature